Slow-release hydrogel doses tumors with drugs

An immunotherapy drug embedded in a slow-release hydrogel appears to be highly effective at killing cancer cells, according to new research. STINGel combines a new class of immunotherapy drugs called stimulator of interferon gene (STING) agonists with an injectable hydrogel...
Read more »